Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma (MREO) Interest Coverage Ratio (2023 - 2025)

Mereo BioPharma (MREO) has disclosed Interest Coverage Ratio for 3 consecutive years, with 357.68 as the latest value for Q3 2025.

  • On a quarterly basis, Interest Coverage Ratio fell 1250.88% to 357.68 in Q3 2025 year-over-year; TTM through Sep 2025 was 77.42, a 165.91% decrease, with the full-year FY2024 number at 34.57, down 250.52% from a year prior.
  • Interest Coverage Ratio was 357.68 for Q3 2025 at Mereo BioPharma, up from 437.46 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 0.79 in Q2 2023 to a low of 437.46 in Q2 2025.
  • A 3-year average of 94.86 and a median of 31.94 in 2024 define the central range for Interest Coverage Ratio.
  • Peak YoY movement for Interest Coverage Ratio: plummeted 4811.92% in 2024, then plummeted 94.87% in 2025.
  • Mereo BioPharma's Interest Coverage Ratio stood at 20.25 in 2023, then tumbled by 101.15% to 40.73 in 2024, then tumbled by 778.1% to 357.68 in 2025.
  • Per Business Quant, the three most recent readings for MREO's Interest Coverage Ratio are 357.68 (Q3 2025), 437.46 (Q2 2025), and 62.23 (Q1 2025).